Business Briefing: Pfizer Breast Cancer Drug Wins Federal Approval
Wednesday, February 4, 2015 - 01:10
in Health & Medicine
The Food and Drug Administration approved Ibrance for women who have tumors that do not contain a protein known as HER-2.